PMS40 COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH GENERIC ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN
Abstract
Authors
M Hiligsmann JY Reginster
M Hiligsmann JY Reginster
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now